Epsilon M&A Deal Report - Kedrion
Transaction Multiples for the Valuation of Private Companies
Fondo Strategico Italiano / Kedrion
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Medical Diagnostic Laboratory
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Laboratory Testing Services
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
Current |
![]() |
Multiple available |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 130
- Number of EMAT Reports / sub-sector « Medical Diagnostic Laboratory » = 55
- Number of EMAT Reports / sub-sector « Laboratory Testing Services » = 36
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 34
Date | Acquirer | Target | Country | Multiples | See details |
25/04/2012 | L'Oréal | Cadum International | France | * | 53556 |
23/01/2013 | Grupo AC Marca SL | Laboratorio Genove | Spain | * | 53462 |
Source: Epsilon Research / EMAT